IL137100A - Tts containing an antioxidant - Google Patents

Tts containing an antioxidant

Info

Publication number
IL137100A
IL137100A IL13710099A IL13710099A IL137100A IL 137100 A IL137100 A IL 137100A IL 13710099 A IL13710099 A IL 13710099A IL 13710099 A IL13710099 A IL 13710099A IL 137100 A IL137100 A IL 137100A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
weight
compound
amount
tocopherol
Prior art date
Application number
IL13710099A
Other languages
English (en)
Other versions
IL137100A0 (en
Original Assignee
Novartis Ag
Lts Lohmann Therapie System Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL137100(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lts Lohmann Therapie System Ag filed Critical Novartis Ag
Publication of IL137100A0 publication Critical patent/IL137100A0/xx
Publication of IL137100A publication Critical patent/IL137100A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13710099A 1998-01-12 1999-01-08 Tts containing an antioxidant IL137100A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (2)

Publication Number Publication Date
IL137100A0 IL137100A0 (en) 2001-06-14
IL137100A true IL137100A (en) 2004-12-15

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13710099A IL137100A (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Country Status (25)

Country Link
US (1) US6335031B1 (pl)
EP (1) EP1047409B1 (pl)
KR (1) KR100569051B1 (pl)
CN (1) CN1129427C (pl)
AT (1) ATE223711T1 (pl)
AU (1) AU745661B2 (pl)
BR (1) BR9906920A (pl)
CA (1) CA2315784C (pl)
CZ (1) CZ300598B6 (pl)
DE (1) DE69902875T2 (pl)
DK (1) DK1047409T3 (pl)
ES (1) ES2184408T3 (pl)
GB (1) GB9800526D0 (pl)
HU (1) HU227159B1 (pl)
ID (1) ID27503A (pl)
IL (1) IL137100A (pl)
MX (1) MXPA00006438A (pl)
NO (1) NO328390B1 (pl)
NZ (1) NZ505650A (pl)
PL (1) PL201328B1 (pl)
PT (1) PT1047409E (pl)
RU (1) RU2219926C2 (pl)
SK (1) SK284622B6 (pl)
TR (2) TR200001688T2 (pl)
WO (1) WO1999034782A1 (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141762A0 (en) * 1998-10-01 2002-03-10 Novartis Ag New oral formulations
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
CN1195506C (zh) * 1999-11-29 2005-04-06 Lts勒曼治疗系统股份公司 具有改良稳定性的经皮治疗系统及其制备方法
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
CN104784180A (zh) * 2008-07-28 2015-07-22 武田药品工业株式会社 药物组合物
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
WO2011076621A2 (de) 2009-12-22 2011-06-30 Acino Ag Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
EP2596071B1 (en) 2010-07-21 2019-02-13 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
SI2468274T1 (sl) 2010-12-14 2015-10-30 Acino Ag Transdermalni terapevtski sistem za dajanje aktivne snovi
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
JP6017543B2 (ja) 2011-05-20 2016-11-02 エスケー ケミカルズ カンパニー, リミテッドSk Chemicals Co., Ltd. リバスティグミン含有パッチ
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
EP2859892B1 (en) 2012-06-12 2023-06-07 KM Transderm Ltd. Patch
JP6269488B2 (ja) * 2012-09-03 2018-01-31 ニプロ株式会社 貼付剤
KR20140038237A (ko) 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US9949935B2 (en) * 2014-04-08 2018-04-24 Teikoku Pharma Usa, Inc. Rivastigmine transdermal compositions and methods of using the same
US10308408B2 (en) 2014-05-15 2019-06-04 Nichiban Co., Ltd. Packaging for adhesive patch containing rivastigmine
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
CA3168199A1 (en) * 2020-02-19 2021-08-26 Eri ICHIBAYASHI Transdermal absorption preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
DE69802498T2 (de) * 1997-01-17 2002-07-04 Takeda Chemical Industries, Ltd. Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Also Published As

Publication number Publication date
CN1288375A (zh) 2001-03-21
HU227159B1 (en) 2010-09-28
PT1047409E (pt) 2002-12-31
NO328390B1 (no) 2010-02-08
EP1047409A1 (en) 2000-11-02
JP2002500178A (ja) 2002-01-08
KR100569051B1 (ko) 2006-04-10
DE69902875T2 (de) 2003-05-22
BR9906920A (pt) 2000-10-10
EP1047409B1 (en) 2002-09-11
NO20003472D0 (no) 2000-07-05
CZ300598B6 (cs) 2009-06-24
SK10532000A3 (sk) 2000-11-07
AU2278599A (en) 1999-07-26
PL201328B1 (pl) 2009-03-31
TR200101021T2 (tr) 2002-06-21
RU2219926C2 (ru) 2003-12-27
NZ505650A (en) 2002-10-25
DE69902875D1 (de) 2002-10-17
SK284622B6 (sk) 2005-08-04
TR200001688T2 (tr) 2000-11-21
CZ20002557A3 (cs) 2000-10-11
NO20003472L (no) 2000-08-07
HUP0004300A3 (en) 2003-05-28
ATE223711T1 (de) 2002-09-15
US6335031B1 (en) 2002-01-01
DK1047409T3 (da) 2002-12-30
MXPA00006438A (es) 2003-07-21
WO1999034782A1 (en) 1999-07-15
KR20010033072A (ko) 2001-04-25
ES2184408T3 (es) 2003-04-01
GB9800526D0 (en) 1998-03-11
CA2315784A1 (en) 1999-07-15
IL137100A0 (en) 2001-06-14
AU745661B2 (en) 2002-03-28
JP3820103B2 (ja) 2006-09-13
HK1034036A1 (en) 2001-10-12
CN1129427C (zh) 2003-12-03
ID27503A (id) 2001-04-12
HUP0004300A2 (hu) 2001-05-28
PL341347A1 (en) 2001-04-09
CA2315784C (en) 2006-06-27

Similar Documents

Publication Publication Date Title
EP1047409B1 (en) Tts containing an antioxidant
AU2017213569B2 (en) Transdermal therapeutic system for administering an active substance
AU2004260583B2 (en) Transdermaltherapeutic system containing a pramipexol active agent
PL175083B1 (pl) Przezskórny układ terapeutyczny do podawania galantaminy na skórę
EP0155229B1 (en) Pharmaceutical compositions
US6316023B1 (en) TTS containing an antioxidant
EP2594261A1 (en) Composition for transdermal administration of rivastigmine
KR20180054833A (ko) 첩부제
WO2014111790A2 (en) Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
JP3820103B6 (ja) 抗酸化剤含有tts
HK1034036B (en) Tts containing an antioxidant
JP2002500178A5 (pl)
KR102710072B1 (ko) 장기 투여용 리바스티그민 패취
IE69475B1 (en) Pharmaceutical compositions
HK1170945A (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
HK1187247B (en) Transdermal therapeutic system for administering an active substance
MXPA06000779A (en) Transdermaltherapeutic system containing a pramipexol active agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired